Crispr Cartoon Explains CRISPR Gene Editing
Students in a class illustrating the CRISPR gene editing tool can use a Crispr Cartoon to explain the problem. The key molecules used in CRISPR tools are too large to travel through the human body. The students used an earlier cartoon to illustrate this problem. The cartoons, which were graded on understanding and communicating the concept, were then printed out and hung in the teacher’s office. Giese was impressed with the students’ energy.
Animation
A CRISPR-Cas cartoon animation combines beautiful imagery with scientific accuracy. The movie depicts the true shape of the Cas protein and communicates a massive amount of information in just a few minutes. While this animation is aimed at the general public, it can also be used by scientists for educational purposes. This makes it a fantastic example of molecular visualization. To view it, visit the Crispr website.
The CRISPR-Cas9 gene editing technique is a difficult concept to visualize, but this animation breaks it down into easy-to-understand steps. The animation was created by the Skoltech and Visual Science teams to demystify a complex biological system. The animation showcases the dynamic mechanisms of the CRISPR-Cas9 tools. While the technology is still in its early days, it has already made significant strides in treating genetic disorders and boosting the immune system to fight cancer.
Gene-editing technique
The recent Crispr cartoon is a fun way to explain the controversial new gene-editing technique. The method, known as CRISPR, is extremely controversial and poses a number of ethical questions. While it works very well on mammalian germline cells, it can have undesirable side effects. As a result, many bioethicists have expressed concern about the use of gene-editing technology to make people physically and intellectually superior.
The new technique, called CRISPR, reduces off-target gene-snipping and promises to improve the effectiveness of the gene-editing tool. The breakthrough technique was created by Feng Zhang, a graduate student at Skoltech. CRISPR is a type of gene-editing technique developed by living things like bacteria. This technology is currently used to treat rare genetic disorders and boost the immune system to fight cancer.
Gene drives
The gene drive is a technology that pushes a specific trait in animals through the population. But what happens if it stops before the desired trait spreads? This is a problem, which scientists have begun to address. Researchers at Cold Spring Harbor Laboratory have suggested that we should embrace resistance and not push too hard for the desired trait. This could lead to the destruction of an entire species. To avoid this, scientists are developing containment strategies and designing drives that stop working after a few generations.
A genetic engineering team did not discover Crispr in their original work. Instead, a team of basic researchers sequenced the genomes of Archaea, the descendants of the first life on Earth. Microbiologists were interested in these genomes and noticed recurring segments of DNA. These recurring segments were known as palindromes, which are repetitive sequences of DNA. They were referred to as weird segments, so scientists decided to name these repeating segments Crispr.
Patent battle
This Crispr cartoon depicts the key players in the CRISPR patent battle, including Jennifer Doudna, Emmanuelle Charpentier, Feng Zhang, Antonio Regalado, and Sharon Begley. It addresses the ambiguity of credit for CRISPR, the ambiguous nature of gene editing, and its societal consequences. And it doesn’t take sides! The cartoon is a highly entertaining read for both scientists and non-scientists.
The CRISPR-based method was developed by Doudna and Charpentier and has the potential to repair gene sequences in any cell. Zhang’s research published this method for editing gene sequences inside animal cells. And UC can appeal to the Federal Circuit. Eventually, a settlement could be reached between the inventors and institutions. If the patent is issued, the parties could distribute money that comes from CRISPR licenses.
This patent controversy has spawned hundreds of patent applications, but it appears to be holding back gene-editing labs around the world. The vast majority of these patent applications, filed since the beginning of the CRISPR revolution, claim only a narrow improvement of existing IP, which should keep innovators out of trouble. The case between Berkeley and Broad will likely be decided by the U.S. Court of Appeals for the Federal Circuit in the coming months. If the Broad Institute loses, they will have to enter into a new licensing agreement.
Our Services
- Biomedical
- Medical Devices
- Cardiology
- Surgical
- Orthopedic
- Training / E-learning
- Character Animation
- Pharmaceutical
- Social Media / Marketing and Branding
- Explainer
- General Services
Want to know how we can help? Have questions? Have a project to discuss? Message us using the contact form below, email us at [email protected] or call us at (512) 591-8024 to meet with a member of our team today.
